Skip to main content

Brain medicine for non-specialists

Category
Level
Beginner

HBP Curriculum: Interdisciplinary Brain Science. Brain medicine for non-specialists

The human mind is a complex system that produces, processes and transmits information in an incomparable manner. Human thoughts and actions depend profoundly on the proper function of neurons. If this function is disrupted, degeneration and disease can be the consequence. This course provides insights into state-of-the-art views on neurodegenerative, neuropsychiatric and neuroimmunological disorders as well as clinical neuroanatomy and clinical aspects of brain imaging. Apart from the scientific understanding of specific disorders and their treatment, it also discusses the latest findings in research and therapeutics. The Medical Informatics Platform developed in the European Human Brain Project is introduced with an example of how a big data approach may have the potential to improve diagnosis and therapeutic concepts of neurological diseases. Contributions for this course come from renowned researchers and clinicians from Israel, Austria and Switzerland.

Course Features
Course appropriate for those with a background in neurobiology or informatics
Insights into state-of-the-art views on neurodegenerative, neuropsychiatric and neuroimmunological disorders
Insights into clinical neuroanatomy and clinical aspects of brain imaging
Discusses the latest findings in research and therapeutics
Lessons of this Course
1
1
Duration:
39:05
Speaker:

This lecture will highlight our current understanding and recent developments in the field of neurodegenerative disease research, as well as the future of diagnostics and treatment of neurodegenerative diseases.

2
2
Duration:
45:27
Speaker:

2nd part of the lecture. This lecture will highlight our current understanding and recent developments in the field of neurodegenerative disease research, as well as the future of diagnostics and treatment of neurodegenerative diseases.

3
5
Duration:
37:36
Speaker:

This lecture focuses on how the immune system can target and attack the nervous system to produce autoimmune responses that may result in diseases such as multiple sclerosis, neuromyelitis and lupus cerebritis manifested by motor, sensory, and cognitive impairments. Despite the fact that the brain is an immune-privileged site, autoreactive lymphocytes producing proinflammatory cytokines can cause active brain inflammation, leading to myelin and axonal loss.

4
6
Duration:
41:56

Most psychiatric disorders (most notably dependence syndromes, depression, psychosis, and autism) are characterized by impaired social interaction, with many patients preferring a drug of abuse. This lecture focuses on the latest research on the neural basis of normal and impaired social interaction.

5
7
Duration:
45:29

This lecture will provide an overview of neuroimaging techniques and their clinical applications.

6
8
Duration:
41:00

This lecture will provide an overview of neuroimaging techniques and their clinical applications

7
9
Duration:
1:02:29
Speaker:

This lecture will highlight our current understanding and recent developments in the field of neurodegenerative disease research, as well as the future of diagnostics and treatment of neurodegenerative diseases

8
10
Duration:
51:49

A basic introduction to clinical presentation of schizophrenia, its etiology, and current treatment options.

9
11
Duration:
37:51

This lecture provides an overview of depression (epidemiology and course of the disorder), clinical presentation, somatic co-morbidity, and treatment options.

10
12
Duration:
55:15
Speaker:

How genetics can contribute to our understanding of psychiatric phenotypes.

11
13
Duration:
1:04:04

The lecture focuses on rationale for employing neuroimaging methods for movement disorders

12
14
Duration:
45:47

An overview of some of the essential concepts in neuropharmacology (e.g. receptor binding, agonism, antagonism), an introduction to pharmacodynamics and pharmacokinetics, and an overview of the drug discovery process relative to diseases of the Central Nervous System.